Zio ECG Utilization Software (ZEUS) System
Overview
The Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies is a sophisticated, cloud-based software solution designed to analyze and report cardiac rhythm data. It is a core component of iRhythm’s end-to-end cardiac monitoring service, which typically includes a wearable Zio monitor (biosensor) that records continuous electrocardiogram (ECG) data for up to 14 days.
ZEUS leverages proprietary deep-learned artificial intelligence (AI) algorithms to detect and classify a wide range of arrhythmias and sinus rhythms from the collected ECG data. This AI-powered analysis is then reviewed and curated by certified cardiographic technicians, who generate a comprehensive end-of-wear report for the prescribing physician.
The system aims to improve diagnostic yield and provider efficiency by offering a longer monitoring period than traditional Holter monitors and providing clinically actionable information. Physicians can access these preliminary findings through the ZioSuite web portal and a dedicated mobile application for review and final interpretation, aiding in arrhythmia diagnosis and management.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI algorithm for arrhythmia detection and classification
- Continuous ECG data analysis (up to 14 days)
- Cloud-based data analytics (AWS EC2 platform)
- Proprietary deep-learned algorithms for enhanced diagnostic accuracy
- ZioSuite web portal and mobile application for healthcare professionals
- Comprehensive end-of-wear reports for physician review
- Integration with Zio wearable biosensors (Zio monitor, Zio Watch)
- HL7-based EHR integration
- Secure data handling with multi-factor authentication, encryption, and role-based access controls
- Patient-triggered event logging for symptomatic episodes
Use Cases
- Aid in arrhythmia diagnosis and management for patients 18 years or older
- Long-term continuous ambulatory cardiac monitoring
- Detection of infrequent or asymptomatic cardiac arrhythmias
- Monitoring and characterization of atrial fibrillation (AFib)
- Proactive identification of patients with elevated arrhythmia risk, especially those with comorbid conditions like Type 2 diabetes, CKD, COPD, and CAD
What Physicians Need to Know
The ZEUS System provides preliminary, end-of-wear reports that serve as an aid in arrhythmia diagnosis and management; final diagnosis should be based on the physician's clinical judgment, experience, and the patient's medical history. It is crucial to ensure accurate and complete patient registration to prevent misdiagnosis or limited functionality. The system is not intended for critical care patients or situations demanding real-time monitoring. Physicians should be aware that QT interval measurements from the ZEUS System may underestimate global QT measurements from a 12-lead ECG. Utilizing the ZioSuite web portal and mobile application can streamline clinical workflows.
The Zio service, including the ZEUS System, offers direct integration with Electronic Health Record (EHR) systems, such as Epic Aura, to streamline cardiac monitoring workflows. This integration enables ordering and registering Zio ECG monitors directly through the EHR and facilitates electronic delivery of Zio reports back into the EHR. Physicians can interpret these reports from their EHR, CVIS, or ZioSuite. The ZEUS System was developed in partnership with Verily, an Alphabet company, and the Zio Watch with ZEUS System is designed as an integrated, prescription-based solution to enhance clinician workflows and patient experience. The system ensures data security with encryption in motion and at rest (HTTPS, AES-256), role-based access controls, and is cloud-based on the AWS EC2 platform with HL7-based EHR integration.
Details
| Category | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Contact for pricing — Not publicly available |
| Deployment | Cloud-based (AWS EC2 platform) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated The Zio ECG Utilization Software (ZEUS) System received FDA 510(k) clearance (K202527) on May 21, 2021. Subsequent clearances include K222389 for the ZEUS System on February 15, 2023, and 510(k) clearance for the Zio Watch with ZEUS System in July 2022 for AFib detection. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Family Medicine, Internal Medicine |
What the Web Says
The Zio ECG Utilization Software (ZEUS) System, developed by iRhythm, is generally well-regarded for its integration with Zio monitors, aiming to streamline ECG data management and analysis for physicians. Reviews highlight its potential to improve workflow efficiency and provide actionable insights from cardiac monitoring data.
Overall: PositiveStrengths
- Seamless integration with Zio XT and AT monitors.
- Streamlined workflow for ECG data management and review.
- Provides comprehensive and actionable insights from cardiac data.
- User-friendly interface for physicians.
- Reduces manual data handling and potential for errors.
- Supports efficient diagnosis and treatment planning.
Limitations
- Learning curve for new users.
- Dependency on the iRhythm ecosystem (Zio monitors).
- Potential for integration challenges with existing EMR systems.
- Cost of implementation and ongoing subscriptions.
- Some users report occasional software glitches or slowness.
- Limited customization options for specific clinical workflows.
Based on reviews from: iRhythm Technologies official website, Physician forums and discussions, Healthcare IT reviews, Medical technology publications, Reddit discussions (r/medicine, r/healthcareit), G2 reviews, Capterra reviews
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Zio ECG Utilization Software (ZEUS) System
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Zio ECG Utilization Software (ZEUS) System.
Frequently Asked Questions
Compare Zio ECG Utilization Software (ZEUS) System
VS
VS
VS
VS
Investors who backed Zio ECG Utilization Software (ZEUS) System
Funded through the company that built this tool.
